Sleep disturbances commonly co-occur with diabetes, yet they are not included in screening recommendations for type 2 diabetes. Should they be?
Veronica Hackethal, MD
In patients with poorly controlled T2DM despite insulin, diet, & exercise therapies, was the SGLT2 inhibitor well tolerated and effective?
A post hoc analysis pooled data from two randomized controlled phase 3 studies to compare the SGLT2i to the DPP-4i as adjunctive treatment.
Could pioglitazone be the first anti-diabetes agent to prevent diabetes progression and improve cardiovascular outcomes?
A large study of celiac disease looked at prevalence of T1DM and T2DM, and health risks associated with having both celiac disease and diabetes.
Researchers explored seasonal variations in hypoglycemia and compared differences in type 1 diabetes and type 2 diabetes.
SGLT2 inhibition has been shown to preserve renal function and decrease albuminuria in animal models, but do these results apply to humans?
A new meta-analysis delved further into the topic of fracture risk with SGLT2 inhibitors. Was new evidence uncovered?
Does butter deserve its bad rap? A meta-analysis examines butter consumption and type 2 diabetes, as well as mortality and cardiovascular disease.
The Mediterranean diet has been linked to decreased risk of metabolic syndrome, diabetes, and CV events, but there is also criticism of these studies.